During the first 6 days after admission, the reduction in clinical MI's was more pronounced than the reduction in silent MI's. At 40 days, however, the reduction in clinical infarctions and silent MI's was comparable. The major limitation of the study may be the source of one of the most interesting findings of the paper. Two meetings are being planned with the FDA for third quarter 1999 and an NDA is currently under review. DNA testing can identify those at high risk for underlying cervical neoplasia.
Pap test results.
These women were recalled for a second Pap smear and HPV testing. It was concluded that a single test for HPV DNA in cervical specimens could identify most women who were at high risk for cervical cancer. The natural history of disease progression and death was studied in close to 2,000 men who underwent radical prostatectomy for clinically localized prostate cancer between 1982 and 1997. None of the patients underwent radiation or hormonal treatment. By 2020, these numbers should increase as the population ages.